In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

High-risk non-metastatic prostate cancer (PCa) has the potential to progress into lethal disease. Treatment options are manifold but, given a lack of surrogate biomarkers, it remains unclear which treatment offers the best results. Several studies have reported circulating tumor cells (CTCs) to be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shukun, Tauber, Gerlinde, Langsenlehner, Tanja, Schmölzer, Linda Maria, Pötscher, Michaela, Riethdorf, Sabine, Kuske, Andra, Leitinger, Gerd, Kashofer, Karl, Czyż, Zbigniew T., Polzer, Bernhard, Pantel, Klaus, Sedlmayr, Peter, Kroneis, Thomas, El-Heliebi, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678903/
https://www.ncbi.nlm.nih.gov/pubmed/31277254
http://dx.doi.org/10.3390/cancers11070933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678903/
https://www.ncbi.nlm.nih.gov/pubmed/31277254
http://dx.doi.org/10.3390/cancers11070933

Ejemplares similares